Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2.

• DOI: 10.1073/pnas.87.13.5094
• Publication Date: 2006-05-31T11:22:10Z
• Authors: J W Lomasney; W Lorenz; L F Allen; K King; J W Regan; T L Yang-Feng; M G Caron; R J Lefkowitz
• Keywords: 0301 basic medicine; alpha; Placenta; Molecular Sequence Data; Sequence Homology; 612; Transfection; Ligands; Binding, Competitive; Polymerase Chain Reaction; Chromosomes; Cell Line; 03 medical and health sciences; Competitive; Pregnancy; Sequence Homology, Nucleic Acid; Receptors; Animals; Humans; Amino Acid Sequence; Cloning, Molecular; Codon; Genomic Library; Nucleic Acid; Base Sequence; Molecular; Binding; Receptors, Adrenergic, alpha; Adrenergic; Chromosomes, Human, Pair 2; Multigene Family; Pair 2; Female; Oligonucleotide Probes; Human; Cloning

Pharmacologic, biochemical, and genetic analyses have demonstrated the existence of multiple alpha 2-adrenergic receptor (alpha 2AR) subtypes. We have cloned a human alpha 2AR by using the polymerase chain reaction with oligonucleotide primers homologous to conserved regions of the previously cloned alpha 2ARs, the genes for which are located on human chromosomes 4 (C4) and 10 (C10). The deduced amino acid sequence encodes a protein of 450 amino acids whose putative topology is similar to that of the family of guanine nucleotide-binding protein-coupled receptors, but whose structure most closely resembles that of the alpha 2ARs. Competition curve analysis of the binding properties of the receptor expressed in COS-7 cells with a variety of adrenergic ligands demonstrates a unique alpha 2AR pharmacology. Hybridization with somatic cell hybrids shows that the gene for this receptor is located on chromosome 2. Northern blot analysis of various rat tissues shows expression in liver and kidney. The unique pharmacology and tissue localization of this receptor suggest that this is an alpha 2AR subtype not previously identified by classical pharmacological or ligand binding approaches.